D-0594-2026 Class II Ongoing

Recalled by Ajanta Pharma USA Inc — Bridgewater, NJ

FDA drug recall D-0594-2026 was initiated by Ajanta Pharma USA Inc on May 27, 2026 and is designated Class II. Reason for recall: Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg. The recall status is ongoing. Affected quantity: 6,143 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 24, 2026
Initiation Date
May 27, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,143 bottles

Product description

Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.

Reason for recall

Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

Distribution pattern

U.S. Nationwide

Code information

Lot: PA00805, expires: 01/31/2029

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0594-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0594-2026. Report a data issue: hello@regdatalab.com.